


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-7.77%
+4.62%
-3.25%
-3.25%
+9.71%
CHRS
Coherus BioSciences
$1.26
Chart
$1.73 (-27.17%)
$1.05 (+20.00%)
$0.77 (+63.64%)
$1.1 (+14.55%)
CHRS has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

CHRS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
CHRS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CHRS Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is CHRS current stock price?
What are CHRS stock strengths?
What risks are associated with CHRS stock?
When is CHRS next earnings report?
What is CHRS market cap and volume?
What is CHRS's current Stock IQ?
Should I buy CHRS stock right now?
Is CHRS a Strong Buy right now?
What does a 'Strong Buy' rating mean for CHRS?
What does a 'Strong Sell' rating mean for CHRS?
What factors influence CHRS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.77%
+4.62%
-3.25%
-3.25%
+9.71%
CHRS
Coherus BioSciences
Current Price
$1.26
Stock Insights
Not Enough Information

Chart
$1.73 (-27.17%)
$1.05 (+20.00%)
$0.77 (+63.64%)
$1.1 (+14.55%)
CHRS Analysts Opinion
CHRS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
CHRS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CHRS Street Sentiment is extremely bullish and have negative views on the near-term outlook
CHRS has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels.
CHRS Latest Analysis
Coherus Oncology Inc. (CHRS) Presents at UBS Global Healthcare Conference 2025 Transcript.
Mon Nov 10, 2025
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114 a Highly Selective anti-CCR8 Cytolytic Antibody. – CHS-114 demonstrated robust and selective depletion of CCR8 Tregs as well as favorable immune remodeling in tumor tissue from head and neck squamous cell carcinoma (HNSCC) patients –
Fri Nov 7, 2025
Coherus BioSciencess Earnings Outlook. Coherus BioSciences (NASDAQ:CHRS) is gearing up to announce its quarterly earnings on Thursday 2025-11-06. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Coherus BioSciences will report an Investors in Coherus BioSciences are eagerly awaiting the company'.s announcement hoping for news of surpassing estimates and positive guidance for the next quarter.It'.s worth noting for ...
Wed Nov 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CHRS Stock trends
CHRS Stock performance
CHRS Stock analysis
CHRS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.